BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2003
View Archived Issues
Protein Design Labs set out new initiatives for 2003
Read More
ViroPharma updates product pipeline
Read More
Axokine granted fast track designation for severe obesity
Read More
CA4P enters new phase I/II trial in advanced cancers
Read More
Campath compared to Rebif in phase II MS study
Read More
BioBypass-PAD fails to meet phase II clinical endpoints in peripheral arterial disease
Read More
Roche presents novel alpha5-selective GABA-A receptor modulators
Read More
Novel cytokine inhibitors discovered by Procter & Gamble researchers
Read More
Lilly claims 5-HT and noradrenaline reuptake inhibitors for pain and other uses
Read More
New MCH receptor modulators in early development at Neurogen
Read More
GSK scientists identify new B-Raf kinase inhibitors
Read More
Peptide CCK modulators and their use in the diagnosis and treatment of cancer
Read More
Successful conclusion of phase I trial of ZP-120
Read More
Celgene summarizes recent clinical development highlights
Read More
Patient treatment under way in phase II trial of DCF-987 for cystic fibrosis
Read More
DX-88 granted E.U. orphan drug status for acquired and hereditary angioedema
Read More
BioSante and Teva to develop hormone therapy product
Read More
Aphios awarded SBIR grant for development of novel antiinfluenza agents
Read More
Medarex and Ability Biomedical to develop fully human antibody therapeutics
Read More
NitroMed and Merck & Co. form NO-based medicines development collaboration
Read More
DOR BioPharma executes option for nontoxic ricin vaccine technology
Read More
Boehringer Ingelheim and Sagres form oncology collaboration
Read More
Promising results obtained with anidulafungin in invasive candidiasis/candidemia
Read More
Potential use of candesartan cilexetil in migraine prophylaxis
Read More
Sildenafil reported effective in preventing antidepressant-associated sexual dysfunction
Read More
Antitumor activity reported for BioVex's OncoVEX(GM-CSF)
Read More
A potential new indication proposed for losartan
Read More